Clinical Trial Update: CMR to Assess Fibrosis in Cardiomyopathy Using Eplerenone [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating eplerenone for assessing fibrosis in cardiomyopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy

Drugs mentioned

• eplerenone (eplerenone)

Snippet

Sponsor: Royal Brompton & Harefield NHS Foundation Trust | Conditions: Cardiomyopathy | Phase 4 | Status: COMPLETED